With prostate cancer the second most common cancer diagnosed in men in Australia and the third most common cause of cancer death, it’s important to be across the latest cancer care pathways.
This evidence-based training course uses case studies to illustrate steps in prevention, early detection, initial investigation and referral pathways for prostate cancer patients.
At the completion of the course, you’ll be able to:
• Describe the current evidence related to prevention, early detection, presentation, initial investigation and referral for prostate cancer.
• Use evidence-based tools and resources to determine patients' risk of prostate cancer and help asymptomatic patients decide whether to proceed with prostate-specific antigen (PSA) testing.
• Identify how to access local diagnostic imaging and specialist appointment referral pathways for patients presenting with signs and symptoms of prostate cancer.
The training module uses the Optimal Care Pathways series of resources, a national standard for high-quality cancer care, endorsed by Cancer Australia, the National Cancer Expert Reference Group (NCERG) and all state and territory governments.
The government is seeking input into the next Victorian Cancer Plan 2020-24. To inform our submission, we’re consulting with the public, clinicians and researchers and would love your input. Register to attend a consultation session or complete our survey.
Cancer is a leading cause of death in Australia. So, with the Voluntary Assisted Dying Act 2017 now law in Victoria, our cancer nurses are preparing to respond to enquiries via our 13 11 20 cancer information and support line.
Australians diagnosed with cancer are being hit by thousands of dollars in hidden out-of-pocket costs for dental care during and after treatment. Cancer Council Victoria is highlighting this issue on World Head and Neck Cancer Day.
Fatigue is one of the most common side effects of cancer treatment. It’s therefore little wonder that Fatigue and Cancer is our most widely distributed fact sheet. Download it to share with cancer patients.